Waters Q4 sales $873M beat guidance; non-GAAP EPS $4.10 up 13% YoY; FY2025 EPS guide $12.70-$13.00

WATERS CORP /DE/

2024-FY EPS reported $10.71 revenue$2,958,387,000

Q4 sales $873M, +6% reported / +8% constant currency; exceeded high-end of guidance range.
Non-GAAP EPS $4.10 (+13% YoY); GAAP EPS $3.88; FX headwind ~9% in Q4.
Full-year sales $2,958M (flat); non-GAAP EPS $11.86 (+1%); operating cash flow $762M; free cash flow $744M (25% of sales).
FY2025 guidance: constant currency sales growth +4.5%–7.0%; non-GAAP EPS $12.70–$13.00; Q1 non-GAAP EPS $2.17–$2.25.
Pharma sales +10% constant currency; instruments +8%, recurring +9% constant currency in Q4.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.